For the Inventor, By the Inventor

Enter assignee name

Bioinvent International Ab

USPTO Granted Patents = 19

CIPO Patents = 1

EPO Patents = 7

Trademarks = 4

Forward Citations = 527

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Björn Frendéus (8 out of 13 patents)

Ingrid Teige (5 out of 11 patents)

Linda Mårtensson (5 out of 7 patents)

4. Carl A Borrebaeck (5 out of 5 patents)

5. Roland Carlsson (4 out of 13 patents)

6. Carl Arne Krister Borrebaeck (3 out of 12 patents)

7. Ulf Hans Eskil Soderlind (3 out of 4 patents)

8. Petra Holmkvist (3 out of 3 patents)

9. Monika Semmrich (3 out of 4 patents)

10. Mark Steven Cragg (1 out of 7 patents)

11. Reimar Abraham (1 out of 6 patents)

12. Jan Nilsson (1 out of 23 patents)

13. Mauricio Redondo-Müller (1 out of 2 patents)

14. Ali Roghanian (1 out of 4 patents)

15. Jenny Mattsson (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 12441805 - Antagonistic anti-TNFR2 antibodies (2025-10-14),

2. 12344673 - Medicaments, uses and methods (2025-07-01),

3. 12291569 - Antibodies and nucleotide sequences, and uses thereof (2025-05-06),

4. 12139547 - Agonistic anti TNFR2 antibody molecules (2024-11-12),

5. 11648310 - Combination of anti-FGFR4-antibody and bile acid sequestrant (2023-05-16),

6. 10351970 - Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligands (2019-07-16),

7. 10191049 - Screening methods and uses thereof (2019-01-29),

8. 9803013 - Biological materials and uses thereof (2017-10-31),

9. 8758749 - Biological materials and uses thereof (2014-06-24),

10. 7943744 - ICAM-1 binding antibodies (2011-05-17),

11. 7521046 - Antibody immunization therapy for treatment of atherosclerosis (2009-04-21),

12. 7432083 - Method for in vitro molecular evolution of protein function (2008-10-07),

13. 6989250 - Method for in vitro molecular evolution of protein function (2006-01-24),

14. 6607881 - Combined ligand and receptor display (2003-08-19),

15. 6495321 - Method for in vitro molecular evolution of protein function (2002-12-17),

BioInvent International AB is a biotech company focused on the discovery and development of therapeutic antibodies to treat cancer. They have a unique antibody discovery platform that enables the creation of next-generation antibody-based drugs. With a strong pipeline of innovative antibody candidates, BioInvent aims to revolutionize cancer treatment through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#22 in Lund

#322 in Sweden

#31,713 in the World

Bioinvent International Ab

Forward Citations = 527

27 inventors:

Björn Frendéus (8 out of 13 patents)

Ingrid Teige (5 out of 11 patents)

Linda Mårtensson (5 out of 7 patents)

4. Carl A Borrebaeck (5 out of 5 patents)

5. Roland Carlsson (4 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…